Wenjun Cheng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
Track Wenjun Cheng automatically
Every clearance here is in the API, with alerts when new ones post.